PRCT Stock Price, Chart, Stats & News

PROCEPT BioRobotics Corporation
Save
1.19B
Market cap
–
Current P/E
–
Forward P/E
PRCT chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 63.70% |
Operating margin | -33.71% |
Pretax margin | -30.96% |
Net margin | -31.02% |
Effective tax rate | -0.20% |
ROA | -18.81% |
ROE | -25.13% |
D/E | 0.14x |
Interest coverage ratio | -11.69x |
PRCT valuation
P/E | – |
P/S | 4.83x |
P/B | 4.01x |
P/CF | -29.99x |
P/FCF | -25.48x |
P/OCF | -29.99x |
PEG | 1.24x |
EV multiple | -21.49x |
About
PROCEPT BioRobotics Corporation specializes in pioneering surgical robotic technologies, offering innovative solutions within the field of urology. Its flagship product is the AquaBeam Robotic System, a sophisticated, image-guided surgical robot designed for minimally invasive urological procedures. This system primarily facilitates Aquablation therapy, which the company also devised, to alleviate lower urinary tract symptoms in male patients diagnosed with benign prostatic hyperplasia (BPH).
Similar securities
Based on sector and market capitalization
Report issue











